This population-based cohort followed 7,428 women diagnosed with Hodgkin lymphoma before age 36 in England and Wales, 1954 to 2010. Over a median 20.2 years, 1,200 women developed 1,467 invasive cancers (standardised incidence ratio 3.3), mostly breast, lung and thyroid. Solid cancer risk rose with radiotherapy dose and fell by 25% between 1954-1989 and 2000-2010. Adjusting for radiotherapy made this fall small and non-significant, whereas adjusting for chemotherapy did not change it. Blood cancer risks did not fall, and cumulative incidence of second cancers reached 36% at 50 years. The cohort excludes women diagnosed at 36 or older and anyone treated after 2010.
Why it is interesting: It links a fall in second solid cancers after Hodgkin lymphoma to changes in radiotherapy across six decades. Excess breast and lung cancer risk persisted beyond 50 years of follow-up.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.